Selling a med spa usually starts with valuation readiness, financial preparation, confidentiality planning, buyer qualification, LOI negotiation, due diligence, and closing transition. Buyers evaluate adjusted EBITDA, treatment mix, provider continuity, recurring revenue, medical director structure, equipment obligations, lease terms, compliance-sensitive operations, and whether the business can transfer after closing.
A strong med spa sale process does not begin with broad exposure. It begins with organizing the business, identifying buyer concerns early, protecting confidentiality, and approaching qualified buyers only when the seller is prepared for diligence.
Short answer: selling a med spa usually takes about 4 to 8 months from engagement to closing. You get a valuation, prepare the business, approach qualified buyers confidentially, negotiate a letter of intent, then work through diligence to closing. This guide covers each step in detail. For the short version and how we run the process, see how to sell a med spa.
The Med Spa Sale Timeline
A med spa sale process often runs several months from preparation to closing, depending on readiness, buyer fit, diligence complexity, provider continuity, and deal terms. The phases are roughly:
| Phase | Duration | What happens |
|---|---|---|
| Valuation baseline | 2 weeks | Confidential intake, financial review, readiness issues |
| Engagement & preparation | 4–6 weeks | Financial rebuild, CIM, buyer list, data room |
| Confidential buyer outreach | 4–6 weeks | Blind outreach, buyer qualification, NDAs, LOI review |
| Diligence & close | 6–10 weeks | QoE, legal diligence, purchase agreement, closing |
Owners should expect the process to require focused time during preparation, management calls, diligence, and the final push to close. The better the materials are prepared before outreach, the fewer avoidable scrambles happen later.
Step 1: Determine What Your Med Spa Is Worth
The process starts with a confidential valuation discussion. The goal is to understand what the med spa may be worth, what could affect buyer confidence, and whether the business is ready for a buyer process.
You will be asked to share:
- Three years of financial statements (P&L and balance sheet)
- Trailing twelve months revenue and adjusted EBITDA estimate
- A breakdown of revenue by service line
- Membership and recurring revenue data
- Lease, equipment, and medical director information
- Current corporate structure (MSO/PC, single entity, etc.)
The advisor reviews the financials on a normalized basis, pressure-tests add-backs, reviews treatment mix and transferability, and discusses a realistic valuation range. For valuation detail, see med spa valuation.
Common mistake at this stage: Sharing the optimistic version of the numbers instead of the supportable version. Buyers will test the financials anyway. Owners who present clean, realistic numbers early get more useful guidance.
Step 2: Prepare the Business for Sale
If the seller decides to move forward, preparation starts before buyer outreach. Buyers will review more than top-line revenue, so the work should cover financials, service-line performance, provider continuity, leases, equipment, staff, and compliance-sensitive structure.
Once engaged, the preparation work begins:
Financial rebuild. Your trailing financials are rebuilt on a buyer-ready basis. Owner compensation normalized. One-time items separated. Recurring versus one-time revenue split. Service mix margin breakdown. The output is the version of the P&L that a buyer or quality-of-earnings firm may test during diligence.
Confidential information memorandum (CIM). A 30–50 page document that tells the story of your business: history, market position, financial performance, growth opportunities, team, and the investment thesis. This is the centerpiece of the marketing process. A good CIM is the difference between a buyer who engages and a buyer who passes.
Anonymous teaser. A 1–2 page summary that does not name the business, the city, or any identifying detail. This is what gets distributed to buyers before they sign an NDA.
Qualified buyer list assembly. The advisor builds a focused buyer list based on fit, capacity, track record, geography, service mix, and likely interest. The goal is not maximum exposure. It is selective qualified buyer outreach when appropriate.
Data room build. A secure online folder containing the documents a buyer will eventually review: financials, tax returns, leases, equipment lists, employment agreements, MSO/PC documentation where relevant, vendor contracts, marketing data, patient retention metrics, and provider information. Building it before market launch — instead of scrambling during diligence — is one of the biggest accelerants of a clean closing.
Common mistake at this stage: Underinvesting in preparation. A buyer can lose confidence quickly if financials, provider continuity, medical director arrangements, leases, or equipment obligations are unclear.
Step 3: Protect Confidentiality
Confidentiality should be planned before buyers are contacted. A blind overview can describe the opportunity without naming the business, city, staff, or other identifying details. Qualified buyers should sign an NDA before receiving sensitive materials.
Step 4: Identify, Qualify, and Approach Buyers
Management calls. A 60–90 minute conversation between the seller and a buyer’s deal team. The buyer asks about strategy, the team, growth, the operating model, provider continuity, and any concerns raised by the materials.
Buyer qualification and IOI review. Buyers who want to advance may submit a non-binding indication of interest: a price range, structure, key terms, conditions, and timeline. Sellers should compare fit, credibility, confidentiality risk, and expected diligence burden, not just headline price.
Selective next-round review. Advancing buyers may receive deeper data room access, additional management interaction, and sometimes a site visit. Access should be staged so sensitive information is released only as buyer seriousness increases.
Step 5: Evaluate IOIs and Negotiate an LOI
Letter of intent (LOI) deadline. Shortlisted buyers submit LOIs with specific price, structure, terms, and exclusivity periods. The seller should compare the economics and obligations before choosing a path.
LOI selection. Selection is not always the highest headline number. A slightly lower price with cleaner terms, more cash at close, less earnout risk, smaller escrow, or a better post-close role may produce a better total economic outcome.
Common mistake at this stage: Picking the highest headline number without understanding the structure. A $5M LOI with $3M cash at close, $1M escrow held for two years, and $1M earnout contingent on performance is not the same as a $4.5M LOI with $4.2M cash at close. Sellers should compare the real economics before signing exclusivity.
IOI, LOI, Purchase Agreement, and Closing
Indication of Interest (IOI): A preliminary, generally non-binding expression of interest that may outline a valuation range, proposed structure, and key assumptions.
Letter of Intent (LOI): A more developed proposal stating the principal deal terms and establishing the framework for diligence and definitive documentation. Most economic terms remain non-binding.
Purchase agreement: The definitive contract setting the transaction terms, representations, warranties, covenants, indemnification provisions, and closing conditions.
Closing: The point at which required documents are executed, closing conditions are satisfied, consideration is delivered as agreed, and ownership transfers.
Step 6: Complete Buyer Due Diligence
Once the LOI is signed, the seller usually enters exclusivity with the chosen buyer for a defined period. During exclusivity, the buyer runs full diligence and the legal teams negotiate the purchase agreement.
Quality of earnings (QoE). The buyer may hire an accounting firm to validate the financial story. They will rebuild EBITDA, test add-backs, scrutinize accounting policies, and produce a report. If preparation was thorough, the QoE is less likely to create surprises. If it was not, the report may be used to renegotiate price or structure.
Legal and regulatory diligence. Buyer-side counsel may review corporate documents, leases, employment agreements, vendor contracts, patient consent forms, MSO/PC structure, state licensing, medical director arrangements, and malpractice coverage. This is not legal advice; sellers should review healthcare, transaction, tax, employment, privacy, and regulatory questions with qualified advisors.
Operational diligence. The buyer’s operations team reviews equipment, facilities, software systems, patient management workflows, marketing channels, and team structure.
Purchase agreement negotiation. The legal teams negotiate the actual contract: representations and warranties, indemnification provisions, working capital target, escrow structure, earnout mechanics (if any), non-compete and non-solicit terms, and closing conditions. This is where deals get won or lost on the line items.
Working capital peg. The buyer requires the business to be delivered with a defined level of working capital at close. If you deliver more, you get a credit; if you deliver less, the price gets reduced. Setting the peg correctly matters.
Closing. Documents signed, funds wired, ownership transferred. There is usually a closing dinner.
Common mistake at this stage: Going dark on the buyer or the advisor. Diligence is intense but finite. Owners who stay engaged, respond quickly, and keep advisors aligned have a better chance of protecting timing and buyer confidence.
Step 7: Negotiate the Purchase Agreement and Close
Most med spa transactions include some form of post-close commitment from the seller. The structure varies:
Full exit. You sign a defined transition period (typically 30–90 days) for documentation handoff, then you are done. Most common in tuck-in transactions to PE-backed platforms with their own management infrastructure.
Transition agreement. You stay on as a consultant or part-time medical director for 6–24 months on a defined contract. Most common when the buyer needs continuity for medical director or clinical leadership reasons.
Employment agreement with rollover. You stay on as an employee (often with a continuing role like Chief Medical Officer or Regional VP) and roll a portion of your sale proceeds into platform equity. Most common in larger platform-tier transactions where the second bite of the apple is meaningful.
The right post-close structure depends on the seller’s goals, the buyer, provider dependence, rollover, earnout terms, and continuity needs.
Common questions about timing
When should I start the process? The owners who get the best outcomes start the conversation with an advisor 12–24 months before they want to be at the closing table. That gives time to fix the things buyers will discount for: owner concentration, missing recurring revenue, inconsistent margins, messy MSO/PC structure. A confidential med spa valuation discussion can help identify which fixes may matter before buyer outreach.
Can I sell faster than about 4 to 8 months? Sometimes, in specific situations: a pre-existing buyer, a clean and prepared business, no diligence surprises, and strong urgency on both sides. Transaction timing varies with preparation, buyer financing, diligence, regulatory requirements, and deal complexity. But the typical answer is no. Trying to compress the timeline usually costs money in the form of a lower price or worse terms. For what drives the timeline, see how long it takes to sell a med spa.
What if I don’t want to wait? You don’t have to. The first conversation can be confidential and low-pressure. Starting the conversation is not the same as starting the sale process.
Frequently Asked Questions
How do I know whether my med spa is ready to sell?
A med spa is better positioned for a sale when its financial records are reliable, compliance documentation is organized, key provider and employee relationships are stable, and the business can operate without excessive dependence on the owner. Buyers also assess growth trends, service mix, patient concentration, and operating systems.
Should I get a valuation before approaching buyers?
Yes. A valuation can establish realistic expectations, identify the factors driving buyer interest, and help compare proposals combining cash, rollover equity, earnouts, or retained ownership. It should inform the strategy without being treated as a guaranteed transaction price.
Can I sell my med spa confidentially?
A structured process can reduce unnecessary disclosure through anonymized outreach, buyer qualification, NDAs, staged information access, and carefully timed stakeholder communication. No adviser or process can guarantee complete secrecy.
What is the difference between an IOI and an LOI?
An IOI is usually an early, non-binding proposal based on limited information. An LOI is more detailed and typically addresses valuation, structure, exclusivity, diligence, and major transaction terms; final obligations are generally established in the definitive purchase agreement.
What does a buyer review during due diligence?
A buyer may review financial statements, tax records, revenue by service and provider, employment and contractor arrangements, leases, licenses, corporate structure, privacy practices, marketing, equipment, insurance, and regulatory compliance. Scope varies by buyer, transaction structure, and applicable law.
Additional Sale Questions
Do I need an attorney before I start the process?
You will need M&A counsel by the time you sign an LOI, but not before. Most owners use a healthcare-experienced transaction attorney who comes in at the LOI stage and runs through close. Many owners use healthcare-experienced transaction counsel by the LOI stage.
Will my employees find out I’m selling?
Not until you tell them. Confidentiality is procedural: anonymous teasers, NDA-gated CIMs, controlled data rooms, off-hours site visits. A disciplined process is designed to reduce the risk of staff, patients, vendors, and competitors learning about the sale prematurely.
What if I get a better offer from outside the structured sale process during the process?
It happens, and we evaluate it on the merits. Sometimes outside offers are real and we incorporate them into the process. Some outside offers are real; others are exploratory. The advisor’s job is to help compare real economics, structure, certainty, and risk.
What if the deal falls apart at diligence?
Some deals do. The most common reasons are diligence surprises (financial, legal, or regulatory) and buyer-side issues (financing, internal approval, change in mandate). The job of the preparation phase is to eliminate seller-side surprises before they happen, and a structured process may leave the seller with alternatives if the chosen buyer falls out, instead of starting from zero.
Related reading: